VitaNova Life Sciences VNOV
OTC VNOV
$1.38 +0.00 (+0.00%)
At close: Aug 19, 2026 · 4:00 PM EDT

VitaNova Life Sciences (VNOV) Notes Payables (2017)

VitaNova Life Sciences' (VNOV) quarterly Notes Payables came in at $6000.0 in Q2 2017.

VitaNova Life Sciences (VNOV) Notes Payables (2017) Analysis & Trends

VitaNova Life Sciences (VNOV) has 1 years of Notes Payables data on file, last reported at $6000.0 in Q2 2017.

  • Quarterly Notes Payables changed N/A year-over-year to $6000.0 in Q2 2017, while the trailing twelve-month figure through Apr 2017 was $6000.0 (changed N/A YoY) and the FY2017 annual result came in at $6000.0, changed N/A from the prior year.
  • Notes Payables was little changed at $6000.0 in Q2 2017.
  • In the past five years, Notes Payables ranged from a high of $6000.0 in Q2 2017 to a low of $6000.0 in Q2 2017.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Mckesson 101.23 Bn 96.07 Bn 3.69 Bn
2 Cencora 61.23 Bn 58.42 Bn 3.61 Bn
3 Cardinal Health 54.35 Bn 49.49 Bn 2.56 Bn
4 Henry Schein 10.03 Bn 9.87 Bn 1.10 Bn
5 Akso Health 820.26 Mn 820.04 Mn -
6 Edap Tms 159.12 Mn 137.58 Mn 7.34 Mn
7 Accendra Health 98.94 Mn 91.29 Mn 263.41 Mn
8 111 30.87 Mn 109.39 Mn 18.18 Mn
9 Cosmos Health 13.30 Mn 10.85 Mn 1.51 Mn
10 VitaNova Life Sciences 11.51 Mn 9.91 Mn 264,662.00

Historic Data

Download Data
DateValue
Apr 30, 2017 6,000.00